| 臺大學術典藏 |
2021-12-14T23:12:34Z |
Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion
|
Chiu, Huai Hsuan; Tsai, Yun Jung; Lo, Chiao; CHING-HUNG LIN; Tsai, I. Lin; CHING-HUA KUO |
| 臺大學術典藏 |
2021-11-21T23:19:45Z |
Development of an LC-MS/MS method to simultaneously quantify therapeutic mAbs and estimate hematocrit values in dried blood spot samples
|
Chiu, Huai Hsuan; Tsai, Yun Jung; Lo, Chiao; Liao, Hsiao Wei; CHING-HUNG LIN; SUNG-CHUN TANG; CHING-HUA KUO |
| 臺大學術典藏 |
2021-11-18T02:20:17Z |
A STABLE ON-LINE SELF-TUNING OPTIMAL PID CONTROLLER FOR A CLASS OF UNKNOWN SYSTEMS
|
Han-Pang Huang; Ching-Hung Lin; HAN-PANG HUANG |
| 臺大學術典藏 |
2021-09-14T23:19:03Z |
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia
|
CHING-HUNG LIN; RUBY YUN-JU HUANG; TZU-PIN LU; KUAN-TING KUO; Lo, Ko Yun; Chen, Ching Hsuan; Chen, I. Chun; YEN-SHEN LU; Chuang, Eric Y.; Thiery, Jean Paul; CHIUN-SHENG HUANG; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-15T00:08:34Z |
Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients
|
Chen, I. Chun; Hu, Fu Chang; CHING-HUNG LIN; Huang, Shu Min; Chang, Dwan Ying; ANN-LII CHENG; YEN-SHEN LU |
| 臺大學術典藏 |
2021-08-12T03:24:50Z |
Chemotherapy in Breast Cancer
|
CHING-HUNG LIN |
| 臺大學術典藏 |
2021-08-12T01:52:18Z |
Nutrition recommendation for breast cancer
|
Tz-Ting, Huang; CHING-HUNG, LIN; Ming-Feng, Hou; Meng-Chuan, Huang |
| 臺大學術典藏 |
2021-07-29T08:38:52Z |
Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients
|
Chen, I-Chun; Hu, Fu-Chang; CHING-HUNG LIN; Huang, Shu-Min; Chang, Dwan-Ying; Cheng, Ann-Lii; Lu, Yen-Shen |
| 臺大學術典藏 |
2021-07-28T06:46:59Z |
Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin
|
CHING-HUNG LIN; Kuo K.-T.; Chuang S.-S.; Kuo S.-H.; Chang J.H.; Chang K.-C.; Hsu H.-C.; Tien H.-F.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-28T06:46:59Z |
Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate
|
CHING-HUNG LIN; Yen R.-F.; Jeng Y.-M.; Tzen C.-Y.; Hsu C.; Hong R.-L. |
| 臺大學術典藏 |
2021-07-28T06:46:58Z |
The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma - Molecular basis and predicting favorable outcome
|
Kuo K.-T.; Hsiao C.-H.; CHING-HUNG LIN; Kuo L.-T.; Huang S.-H.; Lin M.-C. |
| 臺大學術典藏 |
2021-07-28T06:46:58Z |
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline
|
Hong R.-L.; CHING-HUNG LIN; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. |
| 臺大學術典藏 |
2021-07-28T06:46:58Z |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Kuo S.-H.; Lien H.-C.; You S.-L.; Lu Y.-S.; CHING-HUNG LIN; Chen T.-Z.; Huang C.-S. |
| 臺大學術典藏 |
2021-07-28T06:46:58Z |
Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma
|
Kuo K.-T.; Liang C.-W.; Hsiao C.-H.; CHING-HUNG LIN; Chen C.-A.; Sheu B.-C.; Lin M.-C. |
| 臺大學術典藏 |
2021-07-28T06:46:57Z |
Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells
|
Lin H.-J.L.; Zuo T.; CHING-HUNG LIN; Chieh T.K.; Liyanarachchi S.; Sun S.; Shen R.; Deatherage D.E.; Potter D.; Asamoto L.; Lin S.; Yan P.S.; Cheng A.-L.; Ostrowski M.C.; Huang T.H.-M. |
| 臺大學術典藏 |
2021-07-28T06:46:57Z |
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers
|
Huang C.-S.; Kuo S.-H.; Lien H.-C.; Yang S.-Y.; You S.-L.; Shen C.-Y.; CHING-HUNG LIN; Lu Y.-S.; Chang K.-J. |
| 臺大學術典藏 |
2021-07-28T06:46:57Z |
Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia
|
CHING-HUNG LIN; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-28T06:46:56Z |
Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable!
|
Chang D.-Y.; CHING-HUNG LIN; Lu Y.-S. |
| 臺大學術典藏 |
2021-07-28T06:46:55Z |
Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an example
|
Huang C.-S.; CHING-HUNG LIN; Lu Y.-S.; Shen C.-Y. |
| 臺大學術典藏 |
2021-07-28T06:46:45Z |
A Novel 96well-formatted Micro-gap Plate Enabling Drug Response Profiling on Primary Tumour Samples
|
Ma W.-Y.; Hsiung L.-C.; Wang C.-H.; Chiang C.-L.; CHING-HUNG LIN; Huang C.-S.; Wo A.M. |
| 臺大學術典藏 |
2021-07-28T06:46:45Z |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu P.-F.; CHING-HUNG LIN; Kuo C.-H.; Chen W.-W.; Yeh D.-C.; Liao H.-W.; Huang S.-M.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2021-07-28T06:46:40Z |
Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasma
|
Chiu H.-H.; Tsai I.-L.; Lu Y.-S.; CHING-HUNG LIN; Kuo C.-H. |
| 臺大學術典藏 |
2021-07-28T06:46:39Z |
Effect of glucocorticoid use on survival in patients with stage I–III breast cancer
|
CHING-HUNG LIN; Chuang P.-Y.; You S.-L.; Chiang C.-J.; Huang C.-S.; Wang M.-Y.; Chao M.; Lu Y.-S.; Cheng A.-L.; Tang C.-H. |
| 臺大學術典藏 |
2021-07-28T06:46:38Z |
Rebuttal comments on “Glucocorticoids in breast cancer treatment: Real benefit or selection bias?”
|
CHING-HUNG LIN; Tang C.-H. |
| 臺大學術典藏 |
2021-07-28T06:46:37Z |
Treating HR+/HER2? breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression
|
Yeo W.; Ueno T.; CHING-HUNG LIN; Liu Q.; Lee K.-H.; Leung R.; Naito Y.; Park Y.H.; Im S.-A.; Li H.; Yap Y.S.; Lu Y.-S.; The Asian Breast Cancer Cooperative Group |
